Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Post by eSnowdenon Jul 04, 2018 1:36pm

127 Views

Post# 28268023

Dividend would be better than share buy-back

something that would definitely attract investor interest would include paying a meaningful quarterly dividend, say around the 10% range. The current strategy is less about large money-intensive acquisitions & more about sales of lower cost generics. So share buy-backs will reduce the share count somewhat, the existing trading volume is so low, a dividend announcement would definitely spark interest.

Bullboard Posts

Near-term and long-term outlook for gold